Patterns of spread of recurrent intraabdominal sarcoma

  • Tessa A. Sugarbaker
  • David Chang
  • Patricia Koslowe
  • Paul H. Sugarbaker
Part of the Cancer Treatment and Research book series (CTAR, volume 82)

Abstract

Literature exists on the pattern of dissemination of extremity sarcomas; however, little has been published on the patterns of progression of surgically treated retroperitoneal and visceral sarcoma. Vezeridis and Wanebo commented that gastrointestinal sarcomas spread via three routes — local invasion, peritoneal implantation, and hematogenous dissemination [1], They pointed out, and this has become generally accepted, that spread through the lymphatics is a less common occurrence than with adenocarcinoma. Glenn and coworkers documented the patterns of recurrence of soft tissue sarcomas of the retroperitoneum [2]. Peritoneal Sarcomatosis was the most common form of recurrence seen in 7 of 16 (44%) patients. This report cited many differences between sarcomas of the extremity and those of the retroperitoneum. The one of interest was that retroperitoneal tumors were more often adjacent to major vessels, such as the aorta, vena cava, and superior mesenteric vessels. Also, Potter and coworkers acknowledged the tendency of primary sarcomas of the trunk, retroperitoneum, and head and neck also to be more likely to arise in close proximity to vital structures [3].

Keywords

Adenocarcinoma Oncol Sarcoma Hull Peri 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Vezeridis MP, Wanebo HJ. Gastrointestinal Sarcomas. In Ahlgren J, MacDonald J, Gastrointestinal Oncology. Philadelphia: JB Lippincott, 1992, pp 499–505.Google Scholar
  2. 2.
    Glenn J, Sindelar WF, Kinsella T, Glatstein E, Tepper J, Costa J, Baker A, Sugarbaker P, Brennan MF, Seipp C, Wesley R, Young RC, Rosenberg SA. Results of multimodality therapy of resectable soft-tissue sarcomas of the retroperitoneum. Surgery 1985;97: 316–324.PubMedGoogle Scholar
  3. 3.
    Potter DA, Glenn J, Kinsella T, Glatstein E, Lack EE, Restrepo C, White DE, Seipp CA, Wesley R, Rosenberg SA. Patterns of recurrence in patients with high-grade sofe-tissue sarcomas. J Clin Oncol 1985;3:353–366.PubMedGoogle Scholar
  4. 4.
    Sindelar WF. Cancer of the small intestine. In Cancer Principles and Practice of Oncology. Philadelphia: JB Lippincott, 1989, pp 875–894.Google Scholar
  5. 5.
    Jacquet PJ, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In Sugarbaker PH, ed. Peritoneal Carcinomatosis: Principles of Management. Norwell, MA: Kluwer Academic, 1996, pp 359–374.Google Scholar
  6. 6.
    Woolson RF. Statistical Methods for the Analysis of Biomedical Data. New York: John Wiley, 1987.Google Scholar
  7. 7.
    Sugarbaker PH, Cunliffe WJ, Belliveau JF, deBruijn EA, Graves T, Mullins RE, Schlag P. Rationale for integrating early postoperative intraperitoneal chemotherapy (EPIC) into the surgical treatment of gastrointestinal cancer. Semin Oncol 1989;16:83–97.PubMedGoogle Scholar
  8. 8.
    Sugarbaker PH, Graves T, de Bruijn EA, Cunliffe WJ, Mullins RE, Hull WE, Oliff L, Schlag P. Rationale for early postoperative intraperitoneal chemotherapy (EPIC) in patients with advanced gastrointestinal cancer. Cancer Res 1990;50:5790–5794.PubMedGoogle Scholar
  9. 9.
    Sugarbaker PH. Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology. In Sugarbaker PH, ed. Peritoneal Carcinomatosis: Principles of Management. Norwell, MA: Kluwer Academic, 1996, pp 79–100.Google Scholar

Copyright information

© Kluwer Academic Publishers, Boston 1996

Authors and Affiliations

  • Tessa A. Sugarbaker
  • David Chang
  • Patricia Koslowe
  • Paul H. Sugarbaker

There are no affiliations available

Personalised recommendations